1.9294
13-February-25 09:47:07
15 minutes delayed
Stocks
+0.0394
+2.08%
Today's range
1.8113 - 1.9600
ISIN
N/A
Source
NASDAQ
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
30 Jan 2025 06:00:00 By Nasdaq GlobeNewswire